Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma
Most Cited Paper
in RNA modifications and cancer
18 Months Post-Publication
Class of 2026
“Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/rna-modifications-and-cancer/2026/
Topics
FTO · m6A · m6A erasers · hepatocellular carcinoma · extracellular vesicles · extracellular vesicles · GPNMB · syndecan-4 (SDC4) · YTHDF2 · CD8+ T cells · tumor-infiltrating lymphocytes · immune evasion · FTO inhibitor CS2 · anti-PD-1 therapy · sorafenib · m6A · mRNA stability · metastasis · immunotherapy sensitization
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited RNA modifications and cancer Papers, Class of 2026. https://pri.pepkio.com/top-papers/rna-modifications-and-cancer/2026. Accessed 2026-07-22. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459